Sort
30,917 grants matching “tumor microenvironment”
Regulation of tumor associated macrophage function by STAT5 in breast cancer
$499,744Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2025 · CA
High-Throughput Spheroid Screening Platform
$499,717James P Freyer · Bennubio Inc · R44 · FY2019 · GM
High-Throughput Spheroid Screening Platform
$499,717James P Freyer · Bennubio Inc · R44 · FY2020 · GM
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$499,693Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
Role of TIEG1 in Foxp3+Treg development and tumor progression
$499,689Venuprasad K Poojary · Wayne State University · RC1 · FY2010 · CA
Parkin tumor suppression
$499,626Dario C. Altieri · Wistar Institute · R01 · FY2024 · CA
Parkin tumor suppression
$499,626Dario C. Altieri · Wistar Institute · R01 · FY2025 · CA
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
$499,609Weizhou Zhang · University Of Florida · R01 · FY2025 · CA
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology
$499,583Antonio Luigi Amelio · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · DE
Profiling and Characterizing Prostate Cancer Tumor Dormancy in the Bone Marrow
$499,562Robert Vessella · University Of Washington · RC1 · FY2010 · CA
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer
$499,518David Danforth · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Nuclear Structure and Gene Expression
$499,446Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2012 · CA
Role of TIEG1 in Foxp3+Treg development and tumor progression
$499,405Venuprasad K Poojary · Wayne State University · RC1 · FY2009 · CA
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCC's
$499,311Sana D Karam · Washington University · R01 · FY2025 · DE
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
$499,263J. Silvio Gutkind · University Of California, San Diego · R01 · FY2021 · CA
Targeting lymph node metastases to block cancer progression
$499,258Timothy P Padera · Massachusetts General Hospital · R01 · FY2025 · CA
Targeting lymph node metastases to block cancer progression
$499,258Timothy P Padera · Massachusetts General Hospital · R01 · FY2023 · CA
TARGETING AML-STROMAL INTERACTIONS
$499,242John F Dipersio · Washington University · R01 · FY2011 · CA
Tumor-Targeted STING Agonism in Head and Neck Squamous Cell Carcinoma
$499,238Thomas Hayman · Yale University · R37 · FY2025 · CA
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
$499,162Chintan Parekh · Children'S Hospital Of Los Angeles · R01 · FY2023 · AI
Profiling and Characterizing Prostate Cancer Tumor Dormancy in the Bone Marrow
$499,151Robert Vessella · University Of Washington · RC1 · FY2009 · CA
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
$499,018Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Enhancing the Potency and Durability of Immunotherapies
$498,946Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2019 · CA
Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
$498,873Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2024 · CA
Salivary gland response to Desert hedgehog signaling as an antidote to damage from therapeutic radiation
$498,788Philip A Beachy · Stanford University · R01 · FY2025 · DE